JESSICA SMITH: Open Payments
NPI 1922780865 · MCKINNEY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$507 in 19 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $562 · 2025 $507
Food & beverage: $507
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $151 |
| Axsome Therapeutics, Inc. | 1 | $122 |
| Astellas Pharma US Inc | 3 | $60 |
| Novo Nordisk Inc | 2 | $44 |
| Antares Pharma, Inc. | 2 | $36 |
| Abbott Laboratories | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Bausch Health US, LLC | 1 | $18 |
| PFIZER INC. | 1 | $17 |
| Exact Sciences Corporation | 1 | $16 |
Products named: UBRELVY, Auvelity, Veozah, XYOSTED, Wegovy, REXULTI, Ozempic, APLENZIN.
Industry payments across TX — which companies pay providers there.
